Can Fite Biopharma Ltd share price logo

Can Fite Biopharma Ltd Share Price

NYSE: CANF

Small Cap

$0.66

(+-0.08%)

as on

Can Fite Biopharma Ltd Stock Performance

as on September 13, 2025 at 1:28 am IST

  • Day's High

    $0.66
    $0.67

    1.52%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.63
    $3.12
    downward going graph

    4.53%

    Downside

    372.73%

    Upside

    downward going graph

Can Fite Biopharma Ltd share price movements today

Previous Close
$0.66
Open
$0.66
Volume
424.5K
Day's Low - High
$0.66 - $0.67
52 Week Low - High
$0.63 - $3.12

Can Fite Biopharma Ltd Historical Returns

1 Month Return
-4.17 %
3 Month Return
-38.36 %
1 Year Return
-72.52 %
3 Year Return
-92.75 %
5 Year Return
-96.32 %

Can Fite Biopharma Ltd Stock Fundamentals & Key Indicators

Check Can Fite Biopharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.2M

EPS (TTM)

-0.52

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

-264.12%

Can Fite Biopharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Can Fite Biopharma Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$14.2M-96.32%NA0.00%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Can Fite Biopharma Ltd Stock including INR - Dollar returns

The Can Fite Biopharma Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Can Fite Biopharma Ltd investment value today

Current value as on today

₹32,639

Returns

₹67,361

(-67.36%)

Returns from Can Fite Biopharma Ltd Stock

₹72,500 (-72.5%)

Dollar Returns*

₹5,139 (+5.14%)

Can Fite Biopharma Ltd Stock's Interest Amongst Investors

Search interest for Can Fite Biopharma Ltd Stock has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:17% versus previous 30 day period

Can Fite Biopharma Ltd Quarterly Profit & Loss

All numbers in Millions USD

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-2
-3
-2
-1
-1
-1
-2
-2
-2
-2
EBITDA
-2
-3
-2
-1
-1
-1
-2
-2
-2
-2
Interest Expense
0
0
0
-
0
0
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-2
-3
-2
-1
-1
-1
-1
-1
-1
-1
Income Tax Expense
0
0
0
0
0
0
-
-
-
-
Net Income
-2
-2
-2
-1
-1
-1
-1
-1
-1
-1
Net Profit Margin
-1196.57%
-1500.00%
-1218.37%
-852.04%
-898.98%
-1065.81%
-1251.90%
-1251.90%
-1095.53%
-1095.53%

Can Fite Biopharma Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
0
0
3
2
0
0
0
0
0
Gross Profit
0
0
0
3
2
0
0
0
0
0
Operating Income
-6
-8
-7
-5
-12
-14
-12
-10
-8
-8
EBITDA
-6
-8
-7
-6
-11
-14
-12
-10
-8
-8
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
-5
-6
-4
-6
-12
-14
-12
-10
-7
-7
Income Tax Expense
0
0
0
0
0
0
0
0
0
-
Net Income
-4
-6
-4
-6
-13
-14
-12
-10
-7
-7
Net Profit Margin
-2912.29%
-4069.33%
-588.18%
-172.02%
-642.32%
-1940.50%
-1476.55%
-1263.70%
-1027.46%
-1169.14%

Can Fite Biopharma Ltd Quarterly Cash Flow

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Net Income
-4
-2
-1
-1
-1
-1
-1
-1
-1
Operating Cash Flow
-8
0
0
0
-2
-2
-2
-1
-1
Investing Cash Flow
-
-
-
-
-
2
2
-1
-1
Financing Cash Flow
20
-
-
-
-
-
-
3
3
Change in Cash
-3
-1
0
0
0
0
0
-
-

Can Fite Biopharma Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-7
-4
-6
-12
-14
-12
-10
-7
-7
Operating Cash Flow
-8
-9
-4
-10
-12
-9
-10
-8
-7
Investing Cash Flow
0
0
0
0
0
-14
9
0
1
Financing Cash Flow
-
4
4
10
17
20
20
9
6
Change in Cash
-9
-5
0
0
5
-3
-1
1
0

Insights on Can Fite Biopharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -1.97M → -1.96M (in $), with an average increase of 0.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 155.0K → 179.0K (in $), with an average increase of 3.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 148.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 218.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, CANF stock has moved down by -38.0%

About Can Fite Biopharma Ltd

can fite biopharma (canfy) is a biotechnology company based out of 10 bareket street, פ"ת, israel.
OrganisationCan Fite Biopharma Ltd
Headquarters26 Ben Gurion Street, Ramat Gan, Israel, 5257346
IndustryHealth Technology
CEOMr. Motti Farbstein
E-voting on sharesClick here to vote

Key Management of Can Fite Biopharma Ltd

Name

Title

Dr. Pnina Fishman Ph.D.

Founder, Chief Scientific Officer & Executive Chairperson

Mr. Motti Farbstein

CEO and Chief Financial & Operating Officer

Dr. Sari Fishman Ph.D.

Vice President of Business Development

Dr. Stephen A. Harrison FACP, M.D.

Member of Clinical Advisory Board & Consulting Chief Medical Officer

FAQs

What is Can Fite Biopharma Ltd share price today?

Can Fite Biopharma Ltd share price today is $0.66 as on at the close of the market. Can Fite Biopharma Ltd share today touched a day high of $0.67 and a low of $0.66.

What is the 52 week high and 52 week low for Can Fite Biopharma Ltd share?

Can Fite Biopharma Ltd share touched a 52 week high of $3.12 on and a 52 week low of $0.63 on . Can Fite Biopharma Ltd stock price today i.e. is closed at $0.66,which is 78.85% down from its 52 week high and 4.75% up from its 52 week low.

What is Can Fite Biopharma Ltd's market capitalisation today?

Can Fite Biopharma Ltd market capitalisation is $0.00T as on .

How to invest in Can Fite Biopharma Ltd Stock (CANF) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Can Fite Biopharma Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Can Fite Biopharma Ltd Shares that will get you 2.2727 shares as per Can Fite Biopharma Ltd share price of $0.66 per share as on September 13, 2025 at 1:28 am IST.

What is the minimum amount required to buy Can Fite Biopharma Ltd Stock (CANF) from India?

Indian investors can start investing in Can Fite Biopharma Ltd (CANF) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Can Fite Biopharma Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Can Fite Biopharma Ltd share’s latest price of $0.66 as on September 13, 2025 at 1:28 am IST, you will get 15.1515 shares of Can Fite Biopharma Ltd. Learn more about fractional shares .

What are the returns that Can Fite Biopharma Ltd has given to Indian investors in the last 5 years?

Can Fite Biopharma Ltd stock has given -96.32% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?